Get started
Author

Barbara Capaccetti

Observed names: B Capaccetti, B. Capaccetti
OpenAlex ID: A5077129111
Anti-angiogenic therapy: Rationale, challenges and clinical studies
2002 · R. Longo, R. Sarmiento, et al. · Angiogenesis · 143
Thalidomide: a new anticancer drug?
2003 · Massimo Fanelli, Roberta Sarmiento, et al. · Expert Opinion on Investigational Drugs · 42
Prognostic and Predictive Indicators in Operable Breast Cancer
2003 · Alessandro Morabito, Elena Magnani, et al. · Clinical Breast Cancer · 32
Safety and Efficacy of Sunitinib in Patients from Italy with Metastatic Renal Cell Carcinoma: Final Results from an Expanded-Access Trial
2015 · Cora N. Sternberg, Fabio Calabrò, et al. · Oncology · 28
The Combination of Gemcitabine and Vinorelbine is an Active Regimen as Second-Line Therapy in Patients with Metastatic Breast Cancer Pretreated with Taxanes and/or Anthracyclines: a Phase I–II Study
2003 · Alessandro Morabito, Gianfranco Filippelli, et al. · Breast Cancer Research and Treatment · 24
Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: A phase II trial from an Italian cooperative group
2006 · Marco Benasso, Anna Ponzanelli, et al. · Acta Oncologica · 17
PDF
Thalidomide: an old sedative-hypnotic with anticancer activity?
2001 · G Gasparini, A Morabito, et al. · PubMed · 16
Antiangiogenic agents.
2002 · Simonetta Chiara Stani, Barbara Capaccetti, et al. · PubMed · 1
[Innovative treatment in oncology].
2002 · Barbara Capaccetti, Paola Bonginelli, et al. · PubMed
Works count: 9
Citation count: 303
H-index: 7
I10-index: 7
Year
Topic
Type